IMS Health (IMS) Tops Q3 EPS by 3c; Guides FY14 EPS Below Views

IMS Health (NYSE: IMS) reported Q3 EPS of $0.37, $0.03 better than the analyst estimate of $0.34. Revenue for the quarter came in at $656 million versus the consensus estimate of $668.3 million.

IMS Health sees FY2014 EPS of $1.34-$1.36, versus the consensus of $1.38.

For earnings history and earnings-related data on IMS Health (IMS) click here.

You May Also Be Interested In

• Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
• Orange shares down despite reporting in-line core operating profit in Q1
• Enphase Energy tumbles on guidance miss; BMO trims estimates and price target